Insider Selling: Tenet Healthcare (NYSE:THC) EVP Sells 8,000 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Thomas Arnst sold 8,000 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the transaction, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Tenet Healthcare Price Performance

Shares of THC stock traded down $3.29 during trading on Tuesday, hitting $237.30. The company had a trading volume of 982,439 shares, compared to its average volume of 1,130,122. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $247.21. The stock has a market capitalization of $20.64 billion, a price-to-earnings ratio of 14.34, a price-to-earnings-growth ratio of 1.19 and a beta of 1.39. The stock’s 50-day moving average is $210.94 and its two-hundred day moving average is $202.88.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same period in the prior year, the business earned $3.44 EPS. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Tenet Healthcare during the fourth quarter valued at about $248,494,000. Eminence Capital LP purchased a new stake in shares of Tenet Healthcare during the third quarter worth about $225,263,000. Boston Partners lifted its holdings in Tenet Healthcare by 95.0% in the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Wellington Management Group LLP boosted its stake in Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares during the period. Finally, AQR Capital Management LLC raised its position in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on THC. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. UBS Group boosted their price target on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Jefferies Financial Group lifted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Truist Financial increased their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Finally, JPMorgan Chase & Co. upped their price target on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.